Hydra Single-centre Experience - Copenhagen, Denmark
NCT: NCT06342635 · RECRUITING
Brief Summary
The present study aims to evaluate the efficacy and safety of TAVI using the Hydra transcatheter aortic valve (THV) series, in patients with severe aortic stenosis up to 1-year after the procedure. Additionally, the study will assess the role of geometry in the development of new conduction abnormalities based on the analysis of post-operative CT scan at 1-month in patients who had undergone transcatheter aortic valve replacement with a self-expanding Hydra THV series.
Frequently Asked Questions
What is Hydra Single-centre Experience - Copenhagen, Denmark?
Hydra Single-centre Experience - Copenhagen, Denmark is a clinical trial registered under NCT06342635. Current status: RECRUITING.
What is the status of NCT06342635?
The current status of NCT06342635 (Hydra Single-centre Experience - Copenhagen, Denmark) is: RECRUITING.
When did Hydra Single-centre Experience - Copenhagen, Denmark start?
Hydra Single-centre Experience - Copenhagen, Denmark started on 2024-06-18.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.